ID   SURF1_HUMAN             Reviewed;         300 AA.
AC   Q15526; Q5T8T3; Q5T8T4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-JAN-2026, entry version 189.
DE   RecName: Full=Surfeit locus protein 1;
GN   Name=SURF1; Synonyms=SURF-1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7702754; DOI=10.1089/dna.1994.13.1117;
RA   Lennard A., Gaston K., Fried M.;
RT   "The Surf-1 and Surf-2 genes and their essential bidirectional promoter
RT   elements are conserved between mouse and human.";
RL   DNA Cell Biol. 13:1117-1126(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, Kidney, Skin, and Stomach;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   POSSIBLE FUNCTION, AND INVOLVEMENT IN MC4DN1.
RX   PubMed=9843204; DOI=10.1038/3804;
RA   Zhu Z., Yao J., Johns T., Fu K., de Bie I., Macmillan C., Cuthbert A.P.,
RA   Newbold R.F., Wang J., Chevrette M., Brown G.K., Brown R.M.,
RA   Shoubridge E.A.;
RT   "SURF1, encoding a factor involved in the biogenesis of cytochrome c
RT   oxidase, is mutated in Leigh syndrome.";
RL   Nat. Genet. 20:337-343(1998).
RN   [6]
RP   REVIEW, AND VARIANT MC4DN1 ARG-124.
RX   PubMed=11317352; DOI=10.1002/humu.1112.abs;
RA   Pequignot M.O., Dey R., Zeviani M., Tiranti V., Godinot C., Poyau A.,
RA   Sue C., Di Mauro S., Abitbol M., Marsac C.;
RT   "Mutations in the SURF1 gene associated with Leigh syndrome and cytochrome
RT   C oxidase deficiency.";
RL   Hum. Mutat. 17:374-381(2001).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH COA3.
RX   PubMed=26321642; DOI=10.1016/j.celrep.2015.08.009;
RA   Dennerlein S., Oeljeklaus S., Jans D., Hellwig C., Bareth B., Jakobs S.,
RA   Deckers M., Warscheid B., Rehling P.;
RT   "MITRAC7 acts as a COX1-specific chaperone and reveals a checkpoint during
RT   cytochrome c oxidase assembly.";
RL   Cell Rep. 12:1644-1655(2015).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   VARIANT MC4DN1 ARG-124.
RX   PubMed=10558868; DOI=10.1006/bbrc.1999.1662;
RA   Coenen M.J., van den Heuvel L.P., Nijtmans L.G., Morava E., Marquardt I.,
RA   Girschick H.J., Trijbels F.J., Grivell L.A., Smeitink J.A.;
RT   "SURFEIT-1 gene analysis and two-dimensional blue native gel
RT   electrophoresis in cytochrome c oxidase deficiency.";
RL   Biochem. Biophys. Res. Commun. 265:339-344(1999).
RN   [10]
RP   VARIANTS MC4DN1 GLU-124 AND THR-246, AND VARIANT HIS-202.
RX   PubMed=10746561; DOI=10.1007/s004390051028;
RA   Poyau A., Buchet K., Bouzidi M.F., Zabot M.-T., Echenne B., Yao J.,
RA   Shoubridge E.A., Godinot C.;
RT   "Missense mutations in SURF1 associated with deficient cytochrome c oxidase
RT   assembly in Leigh syndrome patients.";
RL   Hum. Genet. 106:194-205(2000).
RN   [11]
RP   VARIANT MC4DN1 ASP-274.
RX   PubMed=10647889; DOI=10.1007/s004399900191;
RA   Teraoka M., Yokoyama Y., Ninomiya S., Inoue C., Yamashita S., Seino Y.;
RT   "Two novel mutations of SURF1 in Leigh syndrome with cytochrome c oxidase
RT   deficiency.";
RL   Hum. Genet. 105:560-563(1999).
RN   [12]
RP   VARIANT MC4DN1 THR-235.
RX   PubMed=14564068;
RA   Piekutowska-Abramczuk D., Popowska E., Pronicka E., Karczmarewicz E.,
RA   Pronicki M., Kmiec T., Krajewska-Walasek M.;
RT   "SURF1 gene mutations in Polish patients with COX-deficient Leigh
RT   syndrome.";
RL   J. Appl. Genet. 42:103-108(2001).
RN   [13]
RP   DEVELOPMENTAL STAGE, VARIANTS MC4DN1 GLU-124 AND THR-246, VARIANT HIS-202,
RP   CHARACTERIZATION OF VARIANTS MC4DN1 GLU-124 AND THR-246, AND
RP   CHARACTERIZATION OF VARIANT HIS-202.
RX   PubMed=16120373; DOI=10.1016/j.mito.2004.05.004;
RA   Dubot A., Hervouet E., Mandon G., Zabot M.T., Godinot C.;
RT   "Pathogenicity of missense mutations in SURF1 deficiency inducing the Leigh
RT   syndrome. Importance in diagnosis.";
RL   Mitochondrion 4:41-47(2004).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-89.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [15]
RP   VARIANT MC4DN1 ARG-227.
RX   PubMed=21937992; DOI=10.1038/nature10423;
RA   Najmabadi H., Hu H., Garshasbi M., Zemojtel T., Abedini S.S., Chen W.,
RA   Hosseini M., Behjati F., Haas S., Jamali P., Zecha A., Mohseni M.,
RA   Puettmann L., Vahid L.N., Jensen C., Moheb L.A., Bienek M., Larti F.,
RA   Mueller I., Weissmann R., Darvish H., Wrogemann K., Hadavi V.,
RA   Lipkowitz B., Esmaeeli-Nieh S., Wieczorek D., Kariminejad R.,
RA   Firouzabadi S.G., Cohen M., Fattahi Z., Rost I., Mojahedi F., Hertzberg C.,
RA   Dehghan A., Rajab A., Banavandi M.J., Hoffer J., Falah M., Musante L.,
RA   Kalscheuer V., Ullmann R., Kuss A.W., Tzschach A., Kahrizi K., Ropers H.H.;
RT   "Deep sequencing reveals 50 novel genes for recessive cognitive
RT   disorders.";
RL   Nature 478:57-63(2011).
RN   [16]
RP   VARIANT MC4DN1 ASP-248.
RX   PubMed=22410471; DOI=10.1016/j.braindev.2012.02.007;
RA   Tanigawa J., Kaneko K., Honda M., Harashima H., Murayama K., Wada T.,
RA   Takano K., Iai M., Yamashita S., Shimbo H., Aida N., Ohtake A., Osaka H.;
RT   "Two Japanese patients with Leigh syndrome caused by novel SURF1
RT   mutations.";
RL   Brain Dev. 34:861-865(2012).
RN   [17]
RP   VARIANTS MC4DN1 GLY-56; PRO-90; GLY-177; GLU-205 AND ARG-257.
RX   PubMed=22488715; DOI=10.1002/humu.22095;
RA   Lee I.C., El-Hattab A.W., Wang J., Li F.Y., Weng S.W., Craigen W.J.,
RA   Wong L.J.;
RT   "SURF1-associated leigh syndrome: A case series and novel mutations.";
RL   Hum. Mutat. 33:1192-1200(2012).
RN   [18]
RP   VARIANT CMT4K TRP-192, AND FUNCTION.
RX   PubMed=24027061; DOI=10.1212/wnl.0b013e3182a4a518;
RA   Echaniz-Laguna A., Ghezzi D., Chassagne M., Mayencon M., Padet S.,
RA   Melchionda L., Rouvet I., Lannes B., Bozon D., Latour P., Zeviani M.,
RA   Mousson de Camaret B.;
RT   "SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease.";
RL   Neurology 81:1523-1530(2013).
RN   [19]
RP   VARIANT MC4DN1 VAL-257.
RX   PubMed=26443249;
RA   Jazayeri R., Hu H., Fattahi Z., Musante L., Abedini S.S., Hosseini M.,
RA   Wienker T.F., Ropers H.H., Najmabadi H., Kahrizi K.;
RT   "Exome Sequencing and Linkage Analysis Identified Novel Candidate Genes in
RT   Recessive Intellectual Disability Associated with Ataxia.";
RL   Arch. Iran. Med. 18:670-682(2015).
RN   [20]
RP   VARIANTS MC4DN1 TYR-178 AND HIS-LEU-GLN-TYR-GLU-270 INS, AND
RP   CHARACTERIZATION OF VARIANTS MC4DN1 TYR-178; SER-258 AND
RP   HIS-LEU-GLN-TYR-GLU-270 INS.
RX   PubMed=29933018; DOI=10.1016/j.gene.2018.06.058;
RA   Li Y., Wen S., Li D., Xie J., Wei X., Li X., Liu Y., Fang H., Yang Y.,
RA   Lyu J.;
RT   "SURF1 mutations in Chinese patients with Leigh syndrome: Novel mutations,
RT   mutation spectrum, and the functional consequences.";
RL   Gene 674:15-24(2018).
RN   [21]
RP   VARIANT MC4DN1 105-LEU--VAL-300 DEL.
RX   PubMed=29715184; DOI=10.2478/enr-2018-0013;
RA   Danis D., Brennerova K., Skopkova M., Kurdiova T., Ukropec J., Stanik J.,
RA   Kolnikova M., Gasperikova D.;
RT   "Mutations in SURF1 are important genetic causes of Leigh syndrome in
RT   Slovak patients.";
RL   Endocrinol. Exp. 52:110-118(2018).
CC   -!- FUNCTION: Component of the MITRAC (mitochondrial translation regulation
CC       assembly intermediate of cytochrome c oxidase complex) complex, that
CC       regulates cytochrome c oxidase assembly. {ECO:0000269|PubMed:24027061,
CC       ECO:0000269|PubMed:9843204, ECO:0000305|PubMed:26321642}.
CC   -!- SUBUNIT: Component of the MITRAC (mitochondrial translation regulation
CC       assembly intermediate of cytochrome c oxidase complex) complex, the
CC       core components of this complex being COA3/MITRAC12 and COX14.
CC       Interacts with COA3. {ECO:0000269|PubMed:26321642}.
CC   -!- INTERACTION:
CC       Q15526; Q9Y2R0: COA3; NbExp=6; IntAct=EBI-3915286, EBI-6570446;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:P09925}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15526-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15526-2; Sequence=VSP_034817;
CC   -!- DEVELOPMENTAL STAGE: Expressed in the fetus (at protein level).
CC       {ECO:0000269|PubMed:16120373}.
CC   -!- DISEASE: Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1)
CC       [MIM:220110]: An autosomal recessive disorder of the mitochondrial
CC       respiratory chain characterized by early-onset, rapidly progressive
CC       encephalopathy, neurodegeneration, and loss of motor and cognitive
CC       skills. Affected individuals show hypotonia, failure to thrive, loss of
CC       the ability to sit or walk, poor communication, poor eye contact,
CC       oculomotor abnormalities, as well as deafness, ataxia, tremor, and
CC       brisk tendon reflexes. Brain imaging shows bilateral symmetric lesions
CC       in the basal ganglia. Lactate levels in serum and cerebrospinal fluid
CC       are increased. Patient tissues show decreased levels and activity of
CC       mitochondrial respiratory complex IV. Death in childhood may occur,
CC       often due to central respiratory failure. {ECO:0000269|PubMed:10558868,
CC       ECO:0000269|PubMed:10647889, ECO:0000269|PubMed:10746561,
CC       ECO:0000269|PubMed:11317352, ECO:0000269|PubMed:14564068,
CC       ECO:0000269|PubMed:16120373, ECO:0000269|PubMed:21937992,
CC       ECO:0000269|PubMed:22410471, ECO:0000269|PubMed:22488715,
CC       ECO:0000269|PubMed:26443249, ECO:0000269|PubMed:29715184,
CC       ECO:0000269|PubMed:29933018, ECO:0000269|PubMed:9843204}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Charcot-Marie-Tooth disease, demyelinating, type 4K (CMT4K)
CC       [MIM:616684]: An autosomal recessive, demyelinating form of Charcot-
CC       Marie-Tooth disease, a disorder of the peripheral nervous system,
CC       characterized by progressive weakness and atrophy, initially of the
CC       peroneal muscles and later of the distal muscles of the arms. Charcot-
CC       Marie-Tooth disease is classified in two main groups on the basis of
CC       electrophysiologic properties and histopathology: primary peripheral
CC       demyelinating neuropathies (designated CMT1 when they are dominantly
CC       inherited) and primary peripheral axonal neuropathies (CMT2).
CC       Demyelinating neuropathies are characterized by severely reduced nerve
CC       conduction velocities (less than 38 m/sec), segmental demyelination and
CC       remyelination with onion bulb formations on nerve biopsy, slowly
CC       progressive distal muscle atrophy and weakness, absent deep tendon
CC       reflexes, and hollow feet. By convention autosomal recessive forms of
CC       demyelinating Charcot-Marie-Tooth disease are designated CMT4. CMT4K
CC       patients manifest upper and lower limbs involvement. Some affected
CC       individuals have nystagmus and late-onset cerebellar ataxia.
CC       {ECO:0000269|PubMed:24027061}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SURF1 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Surfeit 1 (SURF1); Note=Leiden Open Variation
CC       Database (LOVD);
CC       URL="https://databases.lovd.nl/shared/genes/SURF1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z35093; CAA84476.1; -; mRNA.
DR   EMBL; AK291122; BAF83811.1; -; mRNA.
DR   EMBL; AL158826; CAI12836.1; -; Genomic_DNA.
DR   EMBL; AL158826; CAI12837.1; -; Genomic_DNA.
DR   EMBL; BC028314; AAH28314.1; -; mRNA.
DR   EMBL; BC071658; AAH71658.1; -; mRNA.
DR   CCDS; CCDS6966.1; -. [Q15526-1]
DR   PIR; S57749; S57749.
DR   RefSeq; NP_001267716.1; NM_001280787.1.
DR   RefSeq; NP_003163.1; NM_003172.4. [Q15526-1]
DR   AlphaFoldDB; Q15526; -.
DR   SMR; Q15526; -.
DR   BioGRID; 112701; 199.
DR   CORUM; Q15526; -.
DR   FunCoup; Q15526; 1211.
DR   IntAct; Q15526; 45.
DR   STRING; 9606.ENSP00000361042; -.
DR   BindingDB; Q15526; -.
DR   GlyGen; Q15526; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q15526; -.
DR   MetOSite; Q15526; -.
DR   PhosphoSitePlus; Q15526; -.
DR   BioMuta; SURF1; -.
DR   DMDM; 2498973; -.
DR   jPOST; Q15526; -.
DR   MassIVE; Q15526; -.
DR   PaxDb; 9606-ENSP00000361042; -.
DR   PeptideAtlas; Q15526; -.
DR   ProteomicsDB; 60616; -. [Q15526-1]
DR   ProteomicsDB; 60617; -. [Q15526-2]
DR   Pumba; Q15526; -.
DR   Antibodypedia; 18363; 161 antibodies from 29 providers.
DR   DNASU; 6834; -.
DR   Ensembl; ENST00000371974.8; ENSP00000361042.3; ENSG00000148290.11. [Q15526-1]
DR   Ensembl; ENST00000626663.3; ENSP00000487158.1; ENSG00000280627.3. [Q15526-1]
DR   GeneID; 6834; -.
DR   KEGG; hsa:6834; -.
DR   MANE-Select; ENST00000371974.8; ENSP00000361042.3; NM_003172.4; NP_003163.1.
DR   UCSC; uc004cdh.3; human. [Q15526-1]
DR   AGR; HGNC:11474; -.
DR   ClinPGx; PA36259; -.
DR   CTD; 6834; -.
DR   DisGeNET; 6834; -.
DR   GeneCards; SURF1; -.
DR   GeneReviews; SURF1; -.
DR   HGNC; HGNC:11474; SURF1.
DR   HPA; ENSG00000148290; Low tissue specificity.
DR   MalaCards; SURF1; -.
DR   MIM; 185620; gene.
DR   MIM; 220110; phenotype.
DR   MIM; 616684; phenotype.
DR   OpenTargets; ENSG00000148290; -.
DR   Orphanet; 391351; SURF1-related Charcot-Marie-Tooth disease type 4.
DR   VEuPathDB; HostDB:ENSG00000148290; -.
DR   eggNOG; KOG1563; Eukaryota.
DR   GeneTree; ENSGT00530000064194; -.
DR   InParanoid; Q15526; -.
DR   OMA; WYSRDVA; -.
DR   OrthoDB; 10040024at2759; -.
DR   PAN-GO; Q15526; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q15526; -.
DR   PathwayCommons; Q15526; -.
DR   Reactome; R-HSA-9864848; Complex IV assembly.
DR   SignaLink; Q15526; -.
DR   SIGNOR; Q15526; -.
DR   Agora; ENSG00000148290; -.
DR   BioGRID-ORCS; 6834; 54 hits in 1155 CRISPR screens.
DR   GeneWiki; SURF1; -.
DR   GenomeRNAi; 6834; -.
DR   Pharos; Q15526; Tbio.
DR   PRO; PR:Q15526; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q15526; protein.
DR   Bgee; ENSG00000148290; Expressed in apex of heart and 109 other cell types or tissues.
DR   ExpressionAtlas; Q15526; baseline and differential.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; HTP:FlyBase.
DR   GO; GO:0098803; C:respiratory chain complex; TAS:ProtInc.
DR   GO; GO:0004129; F:cytochrome-c oxidase activity; IEA:Ensembl.
DR   GO; GO:0009060; P:aerobic respiration; TAS:ProtInc.
DR   GO; GO:0033617; P:mitochondrial respiratory chain complex IV assembly; IMP:UniProtKB.
DR   GO; GO:0008535; P:respiratory chain complex IV assembly; TAS:ProtInc.
DR   CDD; cd06662; SURF1; 1.
DR   InterPro; IPR002994; Surf1/Shy1.
DR   InterPro; IPR045214; Surf1/Surf4.
DR   PANTHER; PTHR23427; SURFEIT LOCUS PROTEIN; 1.
DR   PANTHER; PTHR23427:SF2; SURFEIT LOCUS PROTEIN 1; 1.
DR   Pfam; PF02104; SURF1; 1.
DR   PROSITE; PS50895; SURF1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Charcot-Marie-Tooth disease; Disease variant;
KW   Leigh syndrome; Membrane; Mitochondrion; Mitochondrion inner membrane;
KW   Neurodegeneration; Neuropathy; Primary mitochondrial disease;
KW   Proteomics identification; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..300
FT                   /note="Surfeit locus protein 1"
FT                   /id="PRO_0000215652"
FT   TRANSMEM        61..79
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        274..290
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         173..184
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_034817"
FT   VARIANT         56
FT                   /note="A -> G (in MC4DN1; benign; dbSNP:rs116779216)"
FT                   /evidence="ECO:0000269|PubMed:22488715"
FT                   /id="VAR_068648"
FT   VARIANT         89
FT                   /note="N -> K (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036340"
FT   VARIANT         90
FT                   /note="L -> P (in MC4DN1; dbSNP:rs782024654)"
FT                   /evidence="ECO:0000269|PubMed:22488715"
FT                   /id="VAR_068649"
FT   VARIANT         105..300
FT                   /note="Missing (in MC4DN1; uncertain significance;
FT                   dbSNP:rs863224228)"
FT                   /evidence="ECO:0000269|PubMed:29715184"
FT                   /id="VAR_083393"
FT   VARIANT         124
FT                   /note="G -> E (in MC4DN1; reduced protein stability;
FT                   dbSNP:rs28933402)"
FT                   /evidence="ECO:0000269|PubMed:10746561,
FT                   ECO:0000269|PubMed:16120373"
FT                   /id="VAR_007450"
FT   VARIANT         124
FT                   /note="G -> R (in MC4DN1; dbSNP:rs782033035)"
FT                   /evidence="ECO:0000269|PubMed:10558868,
FT                   ECO:0000269|PubMed:11317352"
FT                   /id="VAR_015258"
FT   VARIANT         177
FT                   /note="V -> G (in MC4DN1)"
FT                   /evidence="ECO:0000269|PubMed:22488715"
FT                   /id="VAR_068650"
FT   VARIANT         178
FT                   /note="N -> Y (in MC4DN1; uncertain significance; reduces
FT                   protein stability; impairs complex IV assembly;
FT                   dbSNP:rs587753385)"
FT                   /evidence="ECO:0000269|PubMed:29933018"
FT                   /id="VAR_083394"
FT   VARIANT         192
FT                   /note="R -> W (in CMT4K; uncertain significance;
FT                   dbSNP:rs782190413)"
FT                   /evidence="ECO:0000269|PubMed:24027061"
FT                   /id="VAR_076315"
FT   VARIANT         202
FT                   /note="D -> H (in dbSNP:rs72619327)"
FT                   /evidence="ECO:0000269|PubMed:10746561,
FT                   ECO:0000269|PubMed:16120373"
FT                   /id="VAR_007451"
FT   VARIANT         205
FT                   /note="G -> E (in MC4DN1)"
FT                   /evidence="ECO:0000269|PubMed:22488715"
FT                   /id="VAR_068651"
FT   VARIANT         227
FT                   /note="W -> R (in MC4DN1; uncertain significance;
FT                   dbSNP:rs398122806)"
FT                   /evidence="ECO:0000269|PubMed:21937992"
FT                   /id="VAR_068682"
FT   VARIANT         235
FT                   /note="M -> T (in MC4DN1; dbSNP:rs1319811735)"
FT                   /evidence="ECO:0000269|PubMed:14564068"
FT                   /id="VAR_068652"
FT   VARIANT         246
FT                   /note="I -> T (in MC4DN1)"
FT                   /evidence="ECO:0000269|PubMed:10746561,
FT                   ECO:0000269|PubMed:16120373"
FT                   /id="VAR_007452"
FT   VARIANT         248
FT                   /note="A -> D (in MC4DN1)"
FT                   /evidence="ECO:0000269|PubMed:22410471"
FT                   /id="VAR_068653"
FT   VARIANT         257
FT                   /note="G -> R (in MC4DN1)"
FT                   /evidence="ECO:0000269|PubMed:22488715"
FT                   /id="VAR_068654"
FT   VARIANT         257
FT                   /note="G -> V (in MC4DN1; dbSNP:rs1030336089)"
FT                   /evidence="ECO:0000269|PubMed:26443249"
FT                   /id="VAR_083395"
FT   VARIANT         258
FT                   /note="P -> S (in MC4DN1; uncertain significance; reduces
FT                   protein stability; impairs complex IV assembly)"
FT                   /evidence="ECO:0000269|PubMed:29933018"
FT                   /id="VAR_083396"
FT   VARIANT         270
FT                   /note="E -> EHLQYE (in MC4DN1; uncertain significance;
FT                   reduces protein stability; impairs complex IV assembly;
FT                   dbSNP:rs782161777)"
FT                   /evidence="ECO:0000269|PubMed:29933018"
FT                   /id="VAR_083397"
FT   VARIANT         274
FT                   /note="Y -> D (in MC4DN1; dbSNP:rs121918658)"
FT                   /evidence="ECO:0000269|PubMed:10647889"
FT                   /id="VAR_015259"
SQ   SEQUENCE   300 AA;  33331 MW;  EC890EA48A0EDE7A CRC64;
     MAAVAALQLG LRAAGLGRAP ASAAWRSVLR VSPRPGVAWR PSRCGSSAAE ASATKAEDDS
     FLQWVLLLIP VTAFGLGTWQ VQRRKWKLNL IAELESRVLA EPVPLPADPM ELKNLEYRPV
     KVRGCFDHSK ELYMMPRTMV DPVREAREGG LISSSTQSGA YVVTPFHCTD LGVTILVNRG
     FVPRKKVNPE TRQKGQIEGE VDLIGMVRLT ETRQPFVPEN NPERNHWHYR DLEAMARITG
     AEPIFIDANF QSTVPGGPIG GQTRVTLRNE HLQYIVTWYG LSAATSYLWF KKFLRGTPGV
//
